TCP International Holdings Ltd

(TCPI)

By |

Profile

Tricida Inc is a late-stage pharmaceutical company. It is focused on the development and commercialization of its drug candidate, veverimer (TRC101), a non-absorbed, orally-administered polymer designed to treat metabolic acidosis by binding and removing acid from the gastrointestinal, or GI, tract. The primary area of focus is to slow the progression of chronic kidney disease through the treatment of metabolic acidosis.

Contact Information

Website: www.tricida.com
Email: IR@Tricida.com
Main Phone: +1 415 429-7800
Address: 7000 Shoreline Court
Address 2: Suite 201
State: CA
City / Town: South San Francisco
Country: US
Postal Code: 94080

Issuer Information

Exchange: OTO
CEO: Gerrit Klaerner
Employees: 195
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Profile

Tricida Inc is a late-stage pharmaceutical company. It is focused on the development and commercialization of its drug candidate, veverimer (TRC101), a non-absorbed, orally-administered polymer designed to treat metabolic acidosis by binding and removing acid from the gastrointestinal, or GI, tract. The primary area of focus is to slow the progression of chronic kidney disease through the treatment of metabolic acidosis.

Contact Information

Website: www.tricida.com
Email: IR@Tricida.com
Main Phone: +1 415 429-7800
Address: 7000 Shoreline Court
Address 2: Suite 201
State: CA
City / Town: South San Francisco
Country: US
Postal Code: 94080

Issuer Information

Exchange: OTO
CEO: Gerrit Klaerner
Employees: 195
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 1.18 $ 0. (0.00%)
Last Price 1.18 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open N/A High N/A Low N/A Prev Close 1.18
Last Trade Volume 0 52 Wk Hi 2.26 52 Wk Low 0.61
Market Cap 59.1 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 50,048,972.00 EPS (TTM) -4.73 PE Ratio N/A Exchange OTCPK
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 0
Number of Buys 0 0
Number of Sells 0 0
Net Activity 0 0
Last 10 Buys Shares
Ralph M. Della Ratta 1,000
C. Lee Thomas 1,000
Ellis Yan 1,000
Solomon Yan 1,000
Ellis Yan 1,000
Solomon Yan 1,000
Ellis Yan 1,000
Solomon Yan 1,000
George E. Strickler 1,000
Last 10 Sell Shares
N/A 0
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 5 5 5 5
Low Target Price Estimate 2.4 2.4 2.4 2.4
Mean Target Price Estimate 3.7 3.7 3.7 3.7
Standard Deviation 1.84 1.84 1.84 1.84
Date of Most Recent Estimate 08/19/16 08/19/16 08/19/16 08/19/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 2 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 3 3 3 3